Literature DB >> 9356823

Hypertrophy of the breasts in a patient treated with indinavir.

I Herry1, L Bernard, P de Truchis, C Perronne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9356823     DOI： 10.1086/597649

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  7 in total

1.  Hyperlipidemia under treatment with proteinase inhibitors.

Authors:  S Segerer; J R Bogner; R Walli; O Loch; F D Goebel
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

Review 2.  A risk-benefit assessment of HIV protease inhibitors.

Authors:  G J Moyle; B G Gazzard
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

Review 3.  Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?

Authors:  G M Behrens; M Stoll; R E Schmidt
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

4.  Self-perception of body fat changes and HAART adherence in the Women's Interagency HIV Study.

Authors:  Michael Plankey; Peter Bacchetti; Chengshi Jin; Barbara Grimes; Charles Hyman; Mardge Cohen; Andrea A Howard; Phyllis C Tien
Journal:  AIDS Behav       Date:  2008-08-08

Review 5.  Metabolic complications associated with HIV protease inhibitor therapy.

Authors:  David Nolan
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Antiretroviral therapies associated with lipoatrophy in HIV-infected women.

Authors:  Phyllis C Tien; Yolanda Barrón; Jessica E Justman; Charles Hyman; Mardge H Cohen; Mary Young; Andrea Kovacs; Stephen R Cole
Journal:  AIDS Patient Care STDS       Date:  2007-05       Impact factor: 5.078

7.  HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact.

Authors:  Kenneth Lichtenstein; Ashok Balasubramanyam; Rajagopal Sekhar; Eric Freedland
Journal:  AIDS Res Ther       Date:  2007-07-16       Impact factor: 2.250
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.